Why Neuropathic Pain Responds to Cannabis
Neuropathic pain arises from central sensitization and ectopic firing of damaged peripheral nerves. CB1 receptors in spinal cord dorsal horn neurons and peripheral sensory afferents are the primary targets for cannabinoid analgesia in neuropathic pain. THC and CBD activate these receptors, reducing neuronal hyperexcitability and spinal pain transmission. CBD additionally modulates the TRPV1 channel responsible for burning pain sensations and inhibits FAAH, increasing anandamide that naturally dampens pain signaling. This multi-target mechanism explains why cannabinoids reach parts of neuropathic pain that opioids and gabapentinoids miss.
Types of Neuropathic Pain That Respond to Cannabis
Diabetic peripheral neuropathy: CBD reduces burning and shooting pain by 30-45% in clinical trials; shown to protect remaining nerve function against further diabetic damage. Chemotherapy-induced peripheral neuropathy: cannabis reduces taxane and platinum-induced neuropathy in multiple studies. Multiple sclerosis neuropathic pain: Sativex (1:1 THC:CBD spray) is licensed specifically for MS neuropathic pain in the UK and Canada. HIV-associated neuropathy: smoked cannabis reduced pain intensity by 34% in a University of California trial. Post-herpetic neuralgia and complex regional pain syndrome also respond to cannabis-based treatment.
Optimal Cannabis Approach for Nerve Pain
The 1:1 THC:CBD ratio is the most clinically supported for neuropathic pain — better than either cannabinoid alone. Transdermal patches provide consistent 24-hour coverage ideal for chronic neuropathy. Sublingual tinctures allow precise dose titration with faster onset than edibles. For peripheral nerve pain (hands, feet), topical CBD provides localized CB1 receptor activation without systemic effects. Dosing neuropathic pain typically requires higher cannabis doses than other indications — medical cannabis specialist guidance is valuable for optimizing the 1:1 ratio and dose.
Combining Cannabis with Conventional Neuropathy Treatment
Cannabis works synergistically with gabapentin and pregabalin — allowing dose reduction of these sedating medications. A 2018 study found cannabis addition to standard gabapentin therapy produced superior pain relief versus gabapentin alone at lower total drug doses. Cannabis is compatible with duloxetine and tricyclic antidepressants used for neuropathic pain. Avoid combining high-dose THC with strong opioids without medical supervision due to additive CNS depression risk. Regular sleep quality improvement through cannabis is itself analgesic for neuropathic pain — poor sleep amplifies central pain sensitization significantly.